Page 21«..10..20212223..3040..»

Category Archives: Hypertension

Idiopathic Intracranial Hypertension Treatment Market Segmentation by Application, Market landscape, Market size and forecast by 2026 – The Market…

Posted: Published on December 5th, 2020

The Idiopathic Intracranial Hypertension Treatment Market grew in 2019, as compared to 2018, according to our report, Idiopathic Intracranial Hypertension Treatment Market is likely to have subdued growth in 2020 due to weak demand on account of reduced industry spending post Covid-19 outbreak. Further, Idiopathic Intracranial Hypertension Treatment Market will begin picking up momentum gradually from 2021 onwards and grow at a healthy CAGR between 2021-2025 Deep analysis about market status (2016-2019), competition pattern, advantages and disadvantages of products, industry development trends (2019-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to downstream buyers of this industry have been analysed scientifically Continue reading

Posted in Hypertension | Comments Off on Idiopathic Intracranial Hypertension Treatment Market Segmentation by Application, Market landscape, Market size and forecast by 2026 – The Market…

Rigel Announces Two Posters Highlighting TAVALISSE at the 62nd ASH Annual Meeting & Exposition – PRNewswire

Posted: Published on December 5th, 2020

SOUTH SAN FRANCISCO, Calif., Dec.4, 2020 /PRNewswire/ --Rigel Pharmaceuticals, Inc.(Nasdaq: RIGL) today announced that data related to TAVALISSE (fostamatinib disodium hexahydrate) tablets will be presented in two poster presentations at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition to be held virtually December 5-8, 2020. The poster presentations will be made available on the event's website at https://www.hematology.org/meetings/annual-meetingon Saturday, December 5 at 7:30am PT. Rigel will present an analysis of long-term safety data on fostamatinib in more than 3,500 patients at various dosing regimens with immune thrombocytopenia (ITP) or rheumatoid arthritis (RA).Nonew safety signals norcumulative toxicity were observed with up to 62 months (5.2 years) of continuous treatment in ITP patients and up to 81 months (6.8 years) of continuous treatmentin RA patients Continue reading

Posted in Hypertension | Comments Off on Rigel Announces Two Posters Highlighting TAVALISSE at the 62nd ASH Annual Meeting & Exposition – PRNewswire

30 Days of PH: Dealing With The Elephant in the Room – Pulmonary Hypertension News

Posted: Published on December 5th, 2020

Day 29 of 30 Days of PH Topic: Dealing With The Elephant In The Room This is Skarlettes Story @skarletteisdead In December 2015, I was diagnosed with pulmonary hypertension and heart failure. My diagnosis did not come easily. Id been struggling for a long time and it took multiple doctors, three hospitals, seemingly endless tests, and a lot of hard conversations to finally find out what was wrong Continue reading

Posted in Hypertension | Comments Off on 30 Days of PH: Dealing With The Elephant in the Room – Pulmonary Hypertension News

Diabetes, Hypertension Linked to COVID-19-Related Neurological Complications – MD Magazine

Posted: Published on November 26th, 2020

This article was originally published on Diagnostic Imaging. According to a new study, coronavirus disease 2019 (COVID-19) positive patients who had hypertension and type 2 diabetes were more likely to experience the neurological complications, including bleeding in the brain and stroke, that come with the virus Continue reading

Posted in Hypertension | Comments Off on Diabetes, Hypertension Linked to COVID-19-Related Neurological Complications – MD Magazine

Continuous Renal Replacement Therapy Market: Rise in Incidence of Diabetes and Hypertension to Drive Market – BioSpace

Posted: Published on November 26th, 2020

Manufacturers Provide Improved Health Systems to Support Extracorporeal Therapies Growing incidences of acute kidney injury (AKI) have catalyzed the need for improved and quality treatment therapies in the continuous renal replacement therapy (CRRT) landscape. South East Asia and South America, individually, account for ~31% each, of the hospitalized population suffering from acute kidney injury in 2018. Read Report Overview - https://www.transparencymarketresearch.com/continuous-renal-replacement-therapy-market.html With the help of several clinical trials, continuous venovenous haemodiafiltration (CVVHDF) and the continuous venovenous heamofiltration (CVVHF) mode of therapies have helped improve the survival rates in patients suffering from sepsis-induced acute kidney injury (SAKI) Continue reading

Posted in Hypertension | Comments Off on Continuous Renal Replacement Therapy Market: Rise in Incidence of Diabetes and Hypertension to Drive Market – BioSpace

MannKind Receives Final Milestone Payment for Hypertension Treatment – San Fernando Valley Business Journal

Posted: Published on November 26th, 2020

MannKind Corp. in Westlake Village has received its final $12.5 million milestone payment from United Therapeutics, the company said Thursday Continue reading

Posted in Hypertension | Comments Off on MannKind Receives Final Milestone Payment for Hypertension Treatment – San Fernando Valley Business Journal

Hypertension, medications, and risk of severe COVID-19: A Massachusetts community-based observational study – DocWire News

Posted: Published on November 26th, 2020

This article was originally published here J Clin Hypertens (Greenwich). 2020 Nov 21. doi: 10.1111/jch.14101. Continue reading

Posted in Hypertension | Comments Off on Hypertension, medications, and risk of severe COVID-19: A Massachusetts community-based observational study – DocWire News

For better heart health, step to it, pair of studies say – UB News Center

Posted: Published on November 26th, 2020

Release Date: November 24, 2020 BUFFALO, N.Y. If youre sitting down, the findings of two major new studies led by University at Buffalo researchers are likely to get you moving. Women who met the federal physical activity guideline of 30 minutes per day of moderate activity exclusively through walking had a significantly lower risk of developing hypertension, according to a paper published in the November issue of the American Heart Association journal Hypertension Continue reading

Posted in Hypertension | Comments Off on For better heart health, step to it, pair of studies say – UB News Center

Data in Alberta COVID-19 deaths shows hypertension to be dominant pre-existing condition – CTV Toronto

Posted: Published on November 26th, 2020

CALGARY -- Albertas government is now sharing data that shows how many people who have contracted COVID-19 have underlying conditions. But health experts, including Dr. Deena Hinshaw, say Albertans have to remember the virus is not just affecting people who are older or who are sick. Continue reading

Posted in Hypertension | Comments Off on Data in Alberta COVID-19 deaths shows hypertension to be dominant pre-existing condition – CTV Toronto

The proatherogenic effect of high salt diet combined with focal hypoperfusion on spontaneous hypertension rat – DocWire News

Posted: Published on November 26th, 2020

This article was originally published here Zhonghua Yi Xue Za Zhi. Continue reading

Posted in Hypertension | Comments Off on The proatherogenic effect of high salt diet combined with focal hypoperfusion on spontaneous hypertension rat – DocWire News

Page 21«..10..20212223..3040..»